S 2332 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
To require research with respect to fentanyl and xylazine test strips, to authorize the use of grant funds for such test strips, and for other purposes.
Summary
This bill authorizes and promotes the use of fentanyl and xylazine test strips as overdose prevention tools. It clarifies that federal opioid response grants can be used to provide access to test strips and requires first responder training programs to include instruction on carrying and using these test strips. The bill also directs the Department of Health and Human Services to develop research frameworks for improving test strip technology and to study the impact of drug checking supplies on overdose deaths and treatment engagement, with findings to be reported to Congress within two years.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
1 cosponsor
- Sen. Cornyn, John [R-TX] (R-TX)
Actions (2)
- Jul 17, 2025 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. · senate
- Jul 17, 2025 Introduced in Senate
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Full text
IN THE SENATE OF THE UNITED STATES
July 17, 2025
Ms. Hassan (for herself and Mr. Cornyn) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions
A BILL
To require research with respect to fentanyl and xylazine test strips, to authorize the use of grant funds for such test strips, and for other purposes.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “Advancing Lifesaving Efforts with Rapid Test strips for Communities Act” or the “ALERT Communities Act”.
SEC. 2. GRANT PROGRAM FROM STATE AND TRIBAL RESPONSE TO OPIOID USE DISORDERS.
The activities carried out pursuant to section 1003(b)(4)(A) of the 21st Century Cures Act (42 U.S.C. 290ee-3 note) may include facilitating access to products used to prevent overdose deaths by detecting the presence of one or more substances, such as fentanyl and xylazine test strips, to the extent the purchase and possession of such products is consistent with Federal and State law.
SEC. 3. FIRST RESPONDER TRAINING.
Section 546(c) of the Public Health Service Act (42 U.S.C. 290ee- 1(c)) is amended—
(1) in paragraph (3), by striking “; and” and inserting a semicolon;
(2) in paragraph (4), by striking the period and inserting “; and”; and
(3) by adding at the end the following:
“(5) train and provide resources for first responders and members of other relevant community sectors on carrying and facilitating access to fentanyl or xylazine test strips.”.
SEC. 4. RESEARCH AND MARKETING FRAMEWORKS FOR TEST STRIP TECHNOLOGY.
The Secretary of Health and Human Services, in consultation with the Director of the National Institutes of Health, the Director of the Office of National Drug Control Policy, the Commissioner of Food and Drugs, and the Administrator of the Drug Enforcement Administration, shall develop and make publicly available research and marketing frameworks for developing, improving, and evaluating test strip technology for detecting fentanyl and other dangerous substances. Such frameworks shall—
(1) include standards and guidance for manufacturers seeking to develop and test new test strip technology;
(2) emphasize bringing new test strip technology intended for testing human specimens in clinical settings to support on- site clinical decision-making; and
(3) include guidance on available authorization pathways for test strips described in paragraphs (1) and (2).
SEC. 5. STUDY ON FENTANYL TEST STRIP INTERVENTIONS.
The Secretary of Health and Human Services shall—
(1) conduct a study on the impact of the availability, accessibility, and usage of drug checking supplies, including test strips, on frequency of overdose, overdose deaths, and engagement in substance use disorder treatment; and
(2) not later than 2 years after the date of enactment of this Act, submit to Congress a report on the study conducted under paragraph (1). <all>
Comments